Inspyr Therapeutics Competitors and Similar CompaniesClear all

Inspyr Therapeutics's competitors and similar companies include Moleculin Biotech, Cancer Prevention Pharmaceuticals, Revitope Oncology and Amphista Therapeutics.

	Inspyr Therapeutics Inspyr Therapeutics (formerly known as GenSpera) is a development-stage pharmaceutical company focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature.	Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.	Cancer Prevention Pharmaceuticals Cancer Prevention Pharmaceuticals is a company developing therapeutics designed to reduce the risk of cancer and other diseases.	Revitope Oncology Revitope Oncology is a biotechnology company focused on developing of T cell redirecting biologics.	Amphista Therapeutics Amphista Therapeutics is a biopharmaceutical company.
Founding Date	Founding Date 1903	Founding Date 2006	Founding Date 2008	Founding Date 2016	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Westlake Village, US HQ	Locations Houston, US HQ	Locations HQ	Locations Cambridge, US HQ	Locations London, GB HQ Motherwell, GB
Employees	Employees 1	Employees 176% decrease	Employees 5	Employees 717% increase	Employees 625% decrease
Valuation ($)	Valuation ($) 1.4 m	Valuation ($) 7.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($1m) (FY, 2022)	Net income ($33.6m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 5m (almost 9 years ago)	Latest funding round N/A	Latest funding round $ 53m (about 5 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 491k	Total funding raised $ 9.3m	Total funding raised N/A	Total funding raised $ 60.5m